Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −1.1% | ▲ +1.6% | ▲ +33.0% | ▲ +64.8% | ▲ +71.3% | ▲ +144.1% | ▼ −9.3% | ▲ +85.5% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-06-15 | 2026-06-18 | $0.13 |
| 2025-12-16 | 2025-12-19 | $0.16 |
| 2025-06-16 | 2025-06-20 | $0.15 |
| 2024-12-17 | 2024-12-20 | $0.11 |
| 2024-06-11 | 2024-06-17 | $0.11 |
| 2023-12-20 | 2023-12-27 | $0.17 |
| 2023-06-07 | 2023-06-13 | $0.07 |
| 2022-06-09 | 2022-06-15 | $0.14 |
| 2021-12-13 | 2021-12-17 | $0.26 |
| 2021-06-10 | 2021-06-16 | $0.05 |
| 2020-12-14 | 2020-12-18 | $0.04 |
| 2020-06-15 | 2020-06-19 | $0.08 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind IDNA.